Publikationen von Eva Altrock

Rossnagl, S.; Ghura, H.; Groth, C.; Altrock, E.; Jakob, F.; Schott, S.; Wimberger, P.; Link, T.; Kuhlmann, J. D.; Stenzl, A. et al.; Hennenlotter, J.; Todenhoefer, T.; Rojewski, M.; Bieback, K.; Nakchbandi, I.: A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow. Cancer Research 78 (1), S. 129 - 142 (2018)

Sens, C.; Altrock, E.; Rau, K.; Klemis, V.; von Au, A.; Pettera, S.; Uebel, S.; Damm, T.; Tiwari, S.; Moser, M. et al.; Nakchbandi, I. A.: An O-Glycosylation of Fibronectin Mediates Hepatic Osteodystrophy Through alpha 4 beta 1 Integrin. Journal of Bone and Mineral Research 32 (1), S. 70 - 81 (2017)

Rossnagl, S.; Altrock, E.; Sens, C.; Kraft, S.; Rau, K.; Milsom, M. D.; Giese, T.; Samstag, Y.; Nakchbandi, I. A.: EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer. PLoS Biology 14 (9), e1002562 (2016)

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Erratum to “Inhibition of fibronectin deposition improves experimental liver fibrosis” [J Hepatol 2015;62:625–633]. JOURNAL OF HEPATOLOGY 62 (6), S. 1455 - 1456 (2015)

Altrock, E.; Sens, C.; Wuerfel, C.; Vasel, M.; Kawelke, N.; Dooley, S.; Sottile, J.; Nakchbandi, I.: Inhibition of fibronectin deposition improves experimental liver fibrosis. Journal of Hepatology 62 (3), S. 625 - 633 (2015)

Altrock, E.; Sottile, J.; Nakchbandi, I. A.: INHBITION OF MATRIX ACCUMULATION USING SMALL PEPTIDES REVERSES LIVER FIRBOSIS. In Journal of Hepatology, 64, S. S706 - S706. EASL International Liver Congress, Barcelona, SPAIN, 13. April 2016 - 17. April 2016. Elsevier, Amsterdam (2016)